Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

Benzer Materyaller

• ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
  Yazar:: Jentzsch, Madlen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
  Yazar:: Jentzsch, Madlen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
  Yazar:: Grimm, Juliane, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
  Yazar:: Jentzsch, Madlen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
  Yazar:: Brauer, Dominic, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)